Dishman Carbogen Amcis Ltd has developed and manufactured several niche and high added-value Generic APIs in specific therapeutic fields. Our product portfolio focuses on complex intermediates and APIs and covers specific therapeutic areas such as anesthetics, contrast media agents for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes.

Our goal is to be a reliable partner with a strong know-how in API production and committed to manufacturing the highest quality APIs for our clients, with:

• local client support
• facilities approved by globally recognized health agencies
• expertise in process optimization and commercial scale-up into cGMP manufacturing
• worldwide distribution in both regulated and semi-regulated markets
• RSMs captive manufactured to ensure regulatory compliance
• open and flexible approach to customers' needs
• extensive regulatory approval expertise: in-house preparation and submissions of DMFs in EU /USA and several countries worldwide
• expertise in particle size distribution & micronization capabilities enable us to meet customer's specification of particle size

Our highly skilled and motivated Research and Development team have a passion for optimizing chemistry and analytical processes to ensure that we can introduce products rapidly, compliantly, and offer the appropriate value to our clients and ultimately to patients.

We operate continuously on a 3 shift / 6 days per week basis within R&D operations with strict IP protection policies with an almost unrivaled range of chemistry capabilities & expertise, allowing us to offer non-infringing processes.

Our services and products are focused on providing the best possible value on a long-term basis to our clients.